Analysts expect WAVE Life Sciences Ltd. (NASDAQ:WVE) to report $-1.00 EPS on March, 15.They anticipate $0.21 EPS change or 26.58% from last quarter’s $-0.79 EPS. After having $-0.94 EPS previously, WAVE Life Sciences Ltd.’s analysts see 6.38% EPS growth. The stock increased 14.30% or $6.05 during the last trading session, reaching $48.35. About 349,112 shares traded or 78.17% up from the average. WAVE Life Sciences Ltd. (NASDAQ:WVE) has risen 36.01% since February 15, 2017 and is uptrending. It has outperformed by 19.31% the S&P500.
Among 14 analysts covering ConAgra Foods (NYSE:CAG), 9 have Buy rating, 0 Sell and 5 Hold. Therefore 64% are positive. ConAgra Foods had 46 analyst reports since September 16, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Credit Suisse on Friday, December 23. Jefferies maintained Conagra Brands, Inc. (NYSE:CAG) on Thursday, July 6 with “Buy” rating. On Monday, November 14 the stock rating was initiated by UBS with “Neutral”. As per Friday, April 8, the company rating was maintained by Citigroup. The company was upgraded on Thursday, December 14 by Bernstein. The firm has “Hold” rating given on Friday, September 23 by Deutsche Bank. The stock has “Underperform” rating by Bernstein on Tuesday, March 21. JP Morgan reinitiated Conagra Brands, Inc. (NYSE:CAG) on Wednesday, November 9 with “Overweight” rating. The stock of Conagra Brands, Inc. (NYSE:CAG) earned “Buy” rating by Jefferies on Wednesday, July 27. The firm has “Overweight” rating given on Wednesday, April 6 by JP Morgan. See Conagra Brands, Inc. (NYSE:CAG) latest ratings:
21/12/2017 Broker: Barclays Capital Rating: Buy New Target: $43.0
22/12/2017 Broker: Stifel Nicolaus Rating: Buy Old Target: $38.00 New Target: $42.00 Maintain
14/12/2017 Broker: Bernstein Rating: Hold New Target: $38.0 Upgrade
12/12/2017 Broker: UBS Rating: Hold New Target: $37.0 Upgrade
07/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $45.0 Maintain
30/10/2017 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Buy Upgrade
03/10/2017 Broker: Jefferies Rating: Buy New Target: $40.0 Maintain
29/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $45.0 Maintain
25/09/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $42 New Target: $40 Maintain
25/09/2017 Broker: Credit Suisse Rating: Neutral Old Target: $39 New Target: $37 Maintain
Since October 13, 2017, it had 0 buys, and 2 sales for $5.47 million activity. 23,170 shares were sold by Wise Robert G, worth $877,536. Batcheler Colleen sold $4.59M worth of Conagra Brands, Inc. (NYSE:CAG) on Friday, October 13.
The stock increased 0.20% or $0.07 during the last trading session, reaching $35.54. About 4.65 million shares traded or 32.66% up from the average. Conagra Brands, Inc. (NYSE:CAG) has risen 8.39% since February 15, 2017 and is uptrending. It has underperformed by 8.31% the S&P500.
Conagra Brands, Inc., together with its subsidiaries, operates as a food firm in North America. The company has market cap of $14.24 billion. The firm operates through Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice divisions. It has a 21.31 P/E ratio. The Grocery & Snacks segment primarily offers shelf stable food products in various retail channels in the United States.
Investors sentiment increased to 0.99 in 2017 Q3. Its up 0.17, from 0.82 in 2017Q2. It increased, as 53 investors sold Conagra Brands, Inc. shares while 197 reduced holdings. 66 funds opened positions while 181 raised stakes. 310.77 million shares or 1.88% less from 316.73 million shares in 2017Q2 were reported. 2.26 million were reported by Deutsche Commercial Bank Ag. Commerce Natl Bank owns 0.01% invested in Conagra Brands, Inc. (NYSE:CAG) for 20,166 shares. Regentatlantic Cap Limited Liability Company invested in 0.08% or 26,222 shares. Investors reported 6.75 million shares stake. Cullen Frost Bankers Incorporated stated it has 17,274 shares or 0.02% of all its holdings. Gemmer Asset Mngmt Ltd has 0% invested in Conagra Brands, Inc. (NYSE:CAG) for 318 shares. Guggenheim Cap Lc has invested 0.12% of its portfolio in Conagra Brands, Inc. (NYSE:CAG). Nomura Asset Management Limited holds 0.05% of its portfolio in Conagra Brands, Inc. (NYSE:CAG) for 120,029 shares. Monroe Retail Bank And Mi has invested 0.07% in Conagra Brands, Inc. (NYSE:CAG). Nebraska-based Pittenger And Anderson has invested 0.03% in Conagra Brands, Inc. (NYSE:CAG). Dnb Asset Management As holds 0.03% or 58,171 shares. Point72 Asset Management L P invested in 0.01% or 48,000 shares. Icon Advisers reported 0.02% of its portfolio in Conagra Brands, Inc. (NYSE:CAG). Ameriprise Fin holds 0% or 300,240 shares. Cap Guardian Trust, a California-based fund reported 1,000 shares.
WAVE Life Sciences Ltd., a genetic medicines company, designs, develops, and commercializes nucleic acid therapeutic candidates for genetically defined diseases by utilizing proprietary synthetic chemistry drug development platform. The company has market cap of $1.34 billion. The firm is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It currently has negative earnings. It focuses on proprietary programs in neurology in the central nervous system and neuromuscular system.
Among 5 analysts covering WAVE Life Sciences (NASDAQ:WVE), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. WAVE Life Sciences had 5 analyst reports since December 7, 2015 according to SRatingsIntel. The stock of WAVE Life Sciences Ltd. (NASDAQ:WVE) has “Buy” rating given on Monday, December 7 by Suntrust Robinson. Leerink Swann initiated the shares of WVE in report on Monday, December 7 with “Outperform” rating. SunTrust initiated WAVE Life Sciences Ltd. (NASDAQ:WVE) on Monday, December 7 with “Buy” rating. The firm has “Buy” rating given on Monday, December 7 by Jefferies. The firm has “Mkt Outperform” rating by JMP Securities given on Monday, December 7.